Live feed08:00:00·43dPRReleasevia QuantisnowMediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patientsByQuantisnow·Wall Street's wire, on your screen.MNOV· Medicinova IncHealth Care
